Download © Cambridge University Press www.cambridge.org Cambridge

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
Cambridge University Press
0521618134 - Pocket Guide for Cutaneous Medicine and Surgery
Joshua E. Lane
Index
More information
INDEX
abducens nerve (CN VI), 5
Acyclovir, 117
adalimumab (Humira®), 129
admission orders, 3
alefacept (Amevive®), 129–130
anesthesia. See local anesthesia;
topical anesthesia
angioedema, 71–72
angioid streaks (“EIC Shop), 205
antibacterials. See systemic
antibacterials
antibiotic prophylaxis
antibiotics, 44
indications, 44
indications (AHA guidelines), 43
risk factors, 43
anticoagulants and mechanisms, 46
antigens
in dermatologic diseases,
152–153
in paraneoplastic pemphigus,
153
antihistamines, 137
antimalarial agents, 127–128
antimicrobials. See topical
antimicrobials
antinuclear antibodies, 82
antibody, 82
disorder, 82
pattern, 82
target, 82
antiseptic cleaners, 30
antivirals. See systemic antivirals
anti-Xa (unfractionated heparin
anti-Xa; LMWH anti-Xa),
48
arteries, facial, 16–17
autosomal dominant diseases,
174–175
disease, 174–175
gene, 174–175
autosomal recessive diseases,
176–177
disease, 176–177
gene, 176–177
azathioprine (Imuran), 122–123
Azithromycin (macrolide [azalide]),
107
Bacitracin, 112
bacteriology
gram negative, 57
gram positive, 57
biologics, 129–131
bleeding disorders, 50
blue lunulae (“warp”), 205
blue sclera (“gins poem”), 205
botox cosmetic, 37
buccal nerve, 14
carcinoma, basal cell, AJCC staging
for, 94
carcinoma, cutaneous squamous
cell
AJCC staging for, 94
histologic grading of, 95
231
© Cambridge University Press
www.cambridge.org
Cambridge University Press
0521618134 - Pocket Guide for Cutaneous Medicine and Surgery
Joshua E. Lane
Index
More information
232
Cephalexin (cephalosporin),
107–108
cervical nerve, 15
Chanarin-Dorfman syndrome (“idle
PM”), 205
chemical peels
deep, 36
medium, 36
superficial, 36
chemotherapy-induced
hyperpigmentation, 206
CHILD syndrome, 206
chlorhexidine (HibiclensTM ), 30
chloroquine (Aralen), 127
chromoblastomycosis, 206
Churg-Strauss syndrome
(“beansap”), 206–207
Ciprofloxacin (quinolone), 108
Clindamycin, 110–111
closure time-PFA-100 (platelet
function assay), 48
coagulation cascade, 45
Colchicine, 139
collagen, 148–149
chromosome, 148–149
disease, 148–149
tissue distribution, 148–149
type, 148–149
complement system, 67
Conradi-Hunermann syndrome
(“Conradi”), 207
corticosteroid potency, 136
intermediate, 136
long-acting, 136
short acting, 136
Cowden’s syndrome (“got tuba”),
207
CPY 2C9 inducers and inhibitors,
208–209
CPY 2D6 inducers and inhibitors,
209
© Cambridge University Press
Index
cranial nerves, 4–6
abducens (VI), 5
facial (VII), 5
glossopharyngeal (IX), 5–6
hypoglossal (XII), 6
oculomotor (III), 4
olfactory (I), 4
optic (II), 4
spinal accessory (XI), 6
trigeminal (V), 5
trochlear (IV), 4
vagal ((X), 6
vestibulocochlear (VIII), 5
CREST syndrome, 207
cutaneous leishmaniasis, 163
cutaneous T-cell lymphomas
(CTCL), 96
cyclophosphamide (Cytoxan), 125
cyclosporine (Neoral), 123
CYP 1A2 inducers and inhibitors,
208
CYP 3A4 inducers and inhibitors,
209
cytochrome P-450 inducers
(general), 208
cytochrome P-450 inhibitors
(general), 208
cytotoxic agents, 125–126
Dapsone, 121
dermatology lists, 205, 226
dermatology mnemonics, 205, 226
dermatomes, 6–7
dermatopathology, “bodies” in, 223
dermis
big blue balls in, 223
busy, 224
Dicloxacillin (β-lactamase resistant
penicillin), 107
diffuse cutaneous leishmaniasis,
163
www.cambridge.org
Cambridge University Press
0521618134 - Pocket Guide for Cutaneous Medicine and Surgery
Joshua E. Lane
Index
More information
Index
disease, dermatologic
antigen, 152–153
disease, 152–153
size (kD), 152–153
diseases, etiology of, 164–173
DNA viruses, 59
Doxycycline (tetracycline), 105
drugs, miscellaneous, 139–141
dyskeratosis congenita (“plans”),
210
ectothrix infections, 211–212
efaluzimab (Raptiva®), 130
electrosurgery
biterminal, 29
electrocautery, 29
monoterminal, 29
endothrix infections, 212
eosinophilic spongiosis (“See a
chip”), 224
epidermolysis bullosa, 86
dermolytic or dystrophic, 86–87
intraepidermal, 86
junctional, 86
erythema infectiosum (Fifth’s
disease), 77
Erythromycin (macrolide), 106
etanercept (Enbrel®), 131
etiologies. See diseases, etiology of
external carotid artery, 16
facial nerve (CN VII), 5, 14–15
Famciclovir, 118
Finasteride, 138
Fluconazole, 114–115
fluorescent dermatophytes, 212
focal dermal hypoplasia
(Goltz)(“focal”), 212
glossopharyngeal nerve (CN IX),
5–6
© Cambridge University Press
233
green birefringence with polarized
light, 212
grenz zone, 224
Griseofulvin, 115–116
hand-foot-mouth disease, 77
head and neck
anterior cervical triangle, 18
carotid subdivision of, 19
muscular subdivision of, 19
submandibular subdivision of,
18
submental subdivision of, 18
neck triangles, 20
posterior cervical triangle, 20
hemostasis and diagnostics, 47–48
Henoch-Schönlein purpura (“hap”),
213
Hermansky-Pudlak syndrome
(“pudlak”), 213
hexachlorophene (pHisoHexTM ),
30
histochemical staining, 154–155
purpose, 154–155
stain, 154–155
HLA associations, 213
hormone antagonists, 138
Finasteride, 138
Spironolactone, 138
HPV types, 61
diseases, 61
hydroxychloroquine (Plaquenil),
127
hypoglossal nerve (CN XII), 6
immunohistochemical staining, 156
epidermal, 156
hemapoietic, 156–157
mesenchymal, 156
miscellaneous, 157
neuroectodermal, 156
immunology, 66
www.cambridge.org
Cambridge University Press
0521618134 - Pocket Guide for Cutaneous Medicine and Surgery
Joshua E. Lane
Index
More information
234
immunomodulators. See systemic
immunomodulators
infliximab (Remicade®), 131
internal carotid artery, 16
internal maxillary artery, 16
intraepidermal eosinophilic
vesicles, 224
intravenous immunoglobulin
(IVIG), 101
iodine/iodophores (Betadine), 30
isopropyl alcohol (70%), 30
Itraconazole (triazole), 113–114
Ivermectin, 139
Kawasaki disease (mucocutaneous
lymph node syndrome)
(“fresca”), 78, 213
keratins
in disease, 150–151
location, 150
type I, 150
type II, 150
Ketoconazole, 114
LAMB syndrome, 213
lasers and light
infrared, 53
terminology, 53
ultraviolet, 53
uv spectrum wavelengths, 54
visible, 53
leishmaniasis, 163
uncommon forms of, 163
LEOPARD syndrome, 214
Levofloxacin (quinolone), 108–109
lichenoid reactions, drug-induced,
210
lidocaine toxicity, 42
linear IgA dermatosis,
drug-induced, 211
lists. See dermatology lists
© Cambridge University Press
Index
liver biopsies (Roenigk
classification), 120
local anesthesia
alternatives, 41
contraindications, 41
dosing calculations, 40
with epinephrine, 39
without epinephrine, 39
injectable, 40
lupus erythematosus, diagnostic
criteria (“champions nd”),
214
mandibular nerve (CNV3), 12–13,
14
auriculotemporal branch of, 12
buccal branch of, 12
inferior alveolar branch of, 13
mast cell degranulators (nonimmunologic)(“prom”),
215
mastocytosis types (“mast”), 215
maxillary nerve (CN V2), 11
infraorbital branch of, 11
zygomaticofacial branch of, 11
zygomaticotemporal branch of, 11
melanoma
AJCC staging for cutaneous, 91
AJCC-TNM classification, 89–90
Clark’s and Breslow staging of, 93
malignant, 92
5 year survival rates for, 92
surgical management for, 92
Methotrexate, 119
microbiology and immunology,
57–67
complement system, 67
DNA viruses, 59
HPV types, 61
diseases, 61
immunology, 66
www.cambridge.org
Cambridge University Press
0521618134 - Pocket Guide for Cutaneous Medicine and Surgery
Joshua E. Lane
Index
More information
Index
mycobacteria classification, 58
RNA viruses, 60
smallpox
major criteria of, 62
minor criteria of, 62
vaccination complications, 63
vaccination timeline for, 62
verrucae, candida antigen
therapy for, 64
Minocycline (tetracycline), 105
mnemonics. See dermatology
mnemonics
mucocutaneous leishmaniasis, 163
Muir-Torre syndrome (“sank”), 215
Mupirocin (Bactroban), 112
mycobacteria classification, 58
mycophenolate mofetil (Cellcept),
126
nail terminology, 74–75
NAME syndrome, 215
needles
curvature of, 28
ethicon of, 28
length of, 28
syneture of, 28
type of, 28
Neomycin, 112
Netherton syndrome, 215
neurology, 7
Nicotinamide, 139–140
non-inflammatory subepidermal
blister, 225
occipital artery, 16
occlusive wound dressings
alginates, 33
film, 32
foam, 32
hydroactive, 33–34
hydrocolloid, 31–32
hydrofiber, 34
© Cambridge University Press
235
hydrogel, 31
zinc paste bandages, 34
oculomotor exam
CN III, Inferior division, 8
CN III, Superior division, 8
CN IV, 8
CN VI, 8
oculomotor nerve (CN III), 4
olfactory nerve (CN I), 4
operative note, 3–4
opthalmic artery, 16
opthalmic nerve (CN V1), 11
frontalis (supraorbital) branch of,
11
frontalis (supratrochlear) branch
of, 11
lacrimal branch of, 11
nasociliary (anterior ethmoidal
external nasal) branch of, 11
nasociliary (infratrochlear)
branch of, 11
nasociliary (posterior ethmoidal)
branch of, 11
optic nerve (CN II), 4
pachyonychia congenita, 216
painful dermal tumors (“bengal”),
216
panniculitides, lobular, 159
with vasculitis, 159
without vasculitis, 159–160
panniculitides, septal, 158
with vasculitis, 158
without vasculitis, 158
paraneoplastic pemphigus, 153
parasitized histiocytes, 225
partial thromboplastin time (PTT;
activated PTT; APTT), 47
patchy dermal lymphocytic
infiltrates (“5 Ls”), 225
pediatric dermatology, 76–79
www.cambridge.org
Cambridge University Press
0521618134 - Pocket Guide for Cutaneous Medicine and Surgery
Joshua E. Lane
Index
More information
236
perforating disorders (“kerrp”), 216
permethrin (Elimite), 140
pigmentation, drug-induced, 211
POEMS syndrome, 216
Polymyxin B, 112
porphyrias, 83
laboratory evaluation for, 84
posterior auricular artery, 16
pregnancy. See Varicella Zoster
Virus
prothrombin time (PT/INR), 47
pseudocarcinomatous hyperplasia,
226
puritus without skin rash (“herb
mend”), 216–217
PUVA therapy, 142
quinacrine (Atabrine), 127–128
Refsum’s syndrome (phytanic acid
oxidase deficiency)(“crip”),
217
Rifampin, 110
Riley-Day syndrome (“didi data”),
217
RNA viruses, 60
Rombo syndrome (“bath mc”), 217
roseola, 76
rubella (German measles), 76
rubeola (measles), 76
sarcoid syndromes, 218
saturated solution of potassium
iodide (SSKI), 140
scalp layers (“scalp”), 214
scarlet fever, 78
Schnitzler’s syndrome, 218
SCORTEN system, 102
mortality rate, 102
risk factors, 102
signs, dermatologic, 161–162
© Cambridge University Press
Index
Sjögren-Larsson syndrome
(“Larson”), 218
skin grafts
full thickness (FTSG), 35
split thickness (STSG), 35
terminology, 35
types of, 35
skin lesion terminology
primary skin lesions, 73
secondary skin lesions, 73
skin, structure/function of, 88
anchoring filaments, 88
lamina densa, 88
lamina lucida, 88
plasma membrane, 88
sublamina densa, 88
skin types, 143
UVA/UVB based on, 143
smallpox
major criteria of, 62
minor criteria of, 62
vaccination complications, 63
vaccination timeline for, 62
spinal accessory nerve (CN XI), 6
Spironolactone, 138
staining. See histochemical staining;
immunohistochemical
staining
steroidogenesis, 147
subepidermal bullae with
neutrophils (“plaid”), 226
superficial temporal artery, 16
sutures
absorbable, 27
absorption (days), 27
non-absorbable, 27
Sweet’s syndrome, drug-induced,
211
syndromes, 179–201
systemic antibacterials, 105–111
systemic antifungals, 113–116
www.cambridge.org
Cambridge University Press
0521618134 - Pocket Guide for Cutaneous Medicine and Surgery
Joshua E. Lane
Index
More information
Index
systemic antivirals, 117–118
systemic cutaneous lupus
erythematosus,
drug-induced, 210
systemic immunomodulators,
122–123
systemic lupus erythematosus, 80
laboratory test for, 81
systemic lupus erythematosus,
drug-induced, 210
systemic retinoids, 103
acitretin (Soriatane), 103–104
isotretinoin (Accutane), 103
temporal nerve, 14
Terbinafine (allylamine), 113
Tetracycline (tetracycline), 105–106
Thalidomide, 141
topical anesthesia, 38
topical antimicrobials, 112
topical corticosteroids, 132–135
high potency group (II), 132
low potency group (VI), 134
low potency group (VII), 135
mid potency group (IV), 133
mid potency group (V), 133–134
potent group (III), 132–133
super-high potency group (I), 132
toxic epidermal necrolysis (TEN)
protocol, 97–98
triclosan, 30
© Cambridge University Press
237
trigeminal nerve (CN V), 5, 11–13
Trimethoprim-Sulfamethoxazole
(TMP:SMX = 1:5), 109
trochlear nerve (CN IV), 4
vagal nerve (CN X), 6
Valacyclovir, 117–118
Varicella Zoster Virus (VZV), 77
pregnancy and, 79
vasculitis, 158, 159
verrucae, candida antigen therapy
for, 64
vestibulocochlear nerve (CN VIII),
5
visceral leishmaniasis, 163
vitamins (“the rich never pay
cash”), 219
Wegener’s granulomatosis
(“rough”), 218
Wiskott-Aldrich (XLR
inheritance)(“tie”), 219
x-linked dominant diseases, 178
disease, 178
gene, 178
x-linked recessive diseases, 178
disease, 178
gene, 178
zygomatic nerve, 14
www.cambridge.org
Related documents